WVXU: Concern over PFAS in our water may not be over
UC scientist discusses impact of drinking water pollutants in region and nation
The recent movie “Dark Waters” continues to drive conversations about pollutants in the nation’s drinking water. The environmental thriller is based off of the real story of Cincinnati attorney Robert Bilott and an environmental lawsuit he brought against one of the world’s largest chemical companies, DuPont. It was filmed in our region and its subject matter has raised concerns about PFOA, also known as perfluorooctanoic acid, and PFAS, also known as polyfluoroalkyl substances.
Susan Pinney, a professor in the UC Department of Environmental Health and director of the UC Center for Environmental Genetics, has studied the impact of PFOA and PFAS for much of her professional career. She joined Cincinnati Edition to discuss health concerns associated with these pollutants along with officials from the Sierra Club Gender, Equity and Environment Program and the Ohio Environmental Protection Agency.
UC’s Pinney authored a 2017 study that found that residents of the Mid-Ohio River Valley (from Cincinnati north to Huntington, West Virginia) had higher than normal levels of PFOA based on blood samples collected over a 22-year span. The exposure source was likely from drinking water contaminated by the industrial discharges upriver described in “Dark Waters.”
Related Stories
Make Hoxworth Blood Center’s special holiday events part of your family celebrations this December
December 12, 2025
This December, Hoxworth Blood Center, University of Cincinnati, is inviting families across Greater Cincinnati to add something truly meaningful to their holiday traditions: giving the gift of life. With festive community events, beloved local partners and special thank-you gifts for donors, Hoxworth is making it easier, and more heartwarming than ever, to roll up your sleeves and help save lives close to home.
New combination treatment improves multiple myeloma outcomes
December 11, 2025
The University of Cincinnati Cancer Center's Ed Faber, DO, provided commentary to Medscape on the COBRA study that found the combination of carfilzomib combined with lenalidomide and dexamethasone (KRd) shows significantly greater efficacy than the previous standard of care.
Celebrating the newest Bearcats on Decision Day
December 11, 2025
The University of Cincinnati admits its newest Bearcats for Fall 2026. Interest in the university is at an all-time high with more than 35,000 applicants for admission. Decision Day was also a time to celebrate 10 new Marian Spencer Scholarship recipients.